Lamotrigine

Product NDC
46708-417
11-digit product format
467080417
Labeler code
46708
Product ID
46708-417_faee013c-cad2-4abb-904c-e6ff79ba778c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lamotrigine
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Alembic Pharmaceuticals Limited
Application
ANDA211821
Marketing category
ANDA
Marketing start
2024-10-07
Substance
LAMOTRIGINE
Active strength
200 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
U3H27498KSLAMOTRIGINE84057-84-1LAMOTRIGINE

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
46708-417-304670804173030 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-417-30) 2024-10-07NoNoHistorical
46708-417-91467080417911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-417-91) 2024-10-07NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
LamotrigineAlembic Pharmaceuticals Limited2024-10-11Human Prescription Drug Label1